A vaccine that targets cancer cells in combination with the drug letrozole, a standard hormonal therapy against breast cancer, significantly increased survival when tested in mice, a team of UC Davis investigators has found. The findings were published in the journal Clinical Cancer Research...
Source: http://www.medicalnewstoday.com/releases/245452.php
MICRON TECHNOLOGY INC WESTERN DIGITAL CORPORATION AGILENT TECHNOLOGIES, INC. AVAYA INC.
Tidak ada komentar:
Posting Komentar